Folic Acid: Good News for Leukemia Victims


Folic Acid: Good News for Leukemia Victims

You know that chemicals cause leukemia. You know that radiation causes leukemia. Therefore, is it any surprise that conventional chemical and radiation therapies cause leukemia?

Hundreds of cancer survivors each year develop leukemia as a result of previous therapy. Bad enough that it happens at all, but these malignancies tend to be chemotherapy-resistant or difficult to treat. Conventional medicine calls them secondary leukemias, and they are being identified with increasing frequency.

Radiotherapy and many forms of chemotherapy inevitably produce DNA damage, according to Stephen Forman, MD of the City of Hope National Medical Center in Duarte, California. He states that patients undergoing bone marrow transplants are often treated with the very things that cause leukemia.

One study looked at 114 cases of leukemia following conventional ovarian cancer treatment. It was found that the chemotherapy alone increased the patients' risk of leukemia by as much as 12 times compared to surgery. Radiotherapy increased the risk 10 times. The risk of leukemia was greatest four or five years after chemotherapy began and lasted for at least eight years.

Cyclophosphamide, chlorambucil, melphalan, thiotepa and treosulfan were independently associated with increased risk of leukemia. Chlorambucil and melphalan were found to be the most leukemogenic drugs.

The Good News

Folic acid can protect against this effect. Dr Richard Albertini, PhD of the University of Vermont College of Medicine in Burlington studied white blood cells of women who had been treated for breast cancer. He found a high frequency of mutant cells following chemotherapy but -- get this -- only in those with low or marginal blood levels of folic acid. It's amazing what doctors can learn when they figure in the nutritional factor.

Canadian Health Reform Products Ltd.


By Maureen Kennedy Salaman

Share this with your friends